Experts discuss additional factors considered when determining the most effective sequence of therapies for metastatic colorectal cancer, including fruquintinib, regorafenib, and trifluridine + ...
This article is brought to you by Ochsner Health. While overall rates of colorectal cancer have been declining in the United States, the numbers have been steadily increasing among younger patients.
A combination drug treatment doubled survival time for patients with an aggressive form of colorectal cancer, according to late-stage trial data published Friday in The New England Journal of Medicine ...
CX-2051 demonstrated a 28% overall response rate in advanced colorectal cancer, with a 43% response at the highest dose of 10 mg/kg. The disease control rate was 94%, and median progression-free ...
Two years ago, Emma Dimery was told her stage 4 colon cancer was incurable. Today, she is healthy and cancer-free — and she says a last-resort clinical trial saved her life. Dimery, who lives in ...
The results of the phase 3 ATOMIC trial fired another volley in the ongoing debate over adjuvant vs neoadjuvant immunotherapy for patients with locally advanced colon cancer. But experts are divided ...
Most people with colon cancer begin treatment by having surgery to remove their cancer. If colon cancer has spread beyond your colon, you might have chemotherapy first. This can help treat cancer ...
Colorectal surgeon Dr. Julio Garcia-Aguilar says there are a growing number of ways to treat colon and rectal cancer including advances in targeted therapy, surgery, and immunotherapy that can also ...
Leronlimab demonstrated partial or complete responses in advanced metastatic colorectal cancer, supporting its potential in solid tumor oncology. Increased PD-L1 expression in triple-negative breast ...
At 26, most people are juggling rent, careers, and group chats, not life-or-death medical decisions. So when a young woman ...
One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...
Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...